RiaSTAP (FIBRINOGEN HUMAN)

**Product type:** Plasma Derivative

**Active ingredient:** FIBRINOGEN HUMAN

**Strength:** 1300 mg/50mL

**Dosage form:** Injection, Powder, Lyophilized, For Solution

**Route:** Intravenous

**Labeler:** CSL Behring GmbH

**Marketing category:** BLA (BLA125317)

**Pharmacologic class:** Blood Coagulation Factors [CS], Human Blood Coagulation Factor [EPC], Increased Coagulation Activity [PE]